Arkolith/Insider Trading/KRYS/Form 4

Janney Daniel

DirectorKrystal Biotech, Inc. (KRYS) · full profile →Form 4 · filed Mar 3, 2026
Net Selling
Open-Market Buys
$0
Open-Market Sells
$3.3M
Net Open-Market Flow
-$3.3M
Transactions
2
2 non-derivative · 0 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Feb 27, 2026Sell(S)2K$276.17$655K73K
Feb 27, 2026Sell(S)9K$275.45$2.6M76K

Transaction Codes

S
Open-market sale

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001711279-26-000023) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML